WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2012104818) ORAL CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS OF BEPOTASTINE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2012/104818    International Application No.:    PCT/IB2012/050506
Publication Date: 09.08.2012 International Filing Date: 03.02.2012
IPC:
A61K 9/00 (2006.01), A61K 9/16 (2006.01), A61K 9/20 (2006.01), A61K 9/28 (2006.01), A61K 31/4545 (2006.01)
Applicants: LUPIN LIMITED [IN/IN]; 159 CST Road, Kalina, Santacruz (East), State of Maharashtra, Mumbai 400 098 (IN) (For All Designated States Except US).
DESHMUKH, Ashish, Ashokrao [IN/IN]; (IN) (For US Only).
BHUTADA, Pravin, Meghrajji [IN/IN]; (IN) (For US Only).
CHANDRAN, Sajeev [IN/IN]; (IN) (For US Only).
KULKARNI, Shirishkumar [IN/IN]; (IN) (For US Only)
Inventors: DESHMUKH, Ashish, Ashokrao; (IN).
BHUTADA, Pravin, Meghrajji; (IN).
CHANDRAN, Sajeev; (IN).
KULKARNI, Shirishkumar; (IN)
Agent: MAJUMDAR, Subhatosh; S. Majumdar & Co. 5, Harish Mukherjee Road Kolkata 700 025 (IN)
Priority Data:
157/KOL/2011 03.02.2011 IN
Title (EN) ORAL CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS OF BEPOTASTINE
(FR) COMPOSITIONS PHARMACEUTIQUES ORALES À LIBÉRATION CONTRÔLÉE DE BEPOTASTINE
Abstract: front page image
(EN)The present invention relates to oral controlled release pharmaceutical compositions comprising Bepotastine. The oral controlled release pharmaceutical composition comprises Bepotastine or pharmaceutically acceptable salts thereof and at least one release controlling agent. The present invention also provides the use of oral controlled release pharmaceutical compositions of Bepotastine for the treatment of allergic rhinitis and for the treatment of pruritus caused by urticaria.
(FR)La présente invention concerne des compositions pharmaceutiques orales, à libération contrôlée, qui comportent de la Bepotastine. La composition pharmaceutique orale, à libération contrôlée, comporte de la Bepotastine ou des sels de qualité pharmaceutique de celle-ci, et au moins un agent de contrôle de libération. La présente invention concerne également l'utilisation de compositions pharmaceutiques orales à libération contrôlée de Bepotastine pour le traitement d'une rhinite allergique et pour le traitement d'un prurit provoqué par un urticaire.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)